• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胶质瘤的磁共振成像报告:神经肿瘤临床医生对放射科医生的期望]

[MRI reporting of gliomas : What neuro-oncology clinicians expect from radiologists].

作者信息

Huckhagel Torge, Riedel Christian

机构信息

Institut für diagnostische und interventionelle Neuroradiologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland.

出版信息

Radiologie (Heidelb). 2022 Aug;62(8):683-691. doi: 10.1007/s00117-022-01014-6. Epub 2022 May 25.

DOI:10.1007/s00117-022-01014-6
PMID:35913575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9343312/
Abstract

BACKGROUND AND OBJECTIVE

Structured reporting of MRI examinations using consensus-based content categories has the potential to improve interdisciplinary communication in neuro-oncology. Therefore, the aim of this study was to determine the essential reporting categories in the imaging of gliomas from a clinical perspective within the setting of a nationwide survey of members of medical societies working in neuro-oncology.

MATERIALS AND METHODS

An online questionnaire was created based on an interdisciplinary developed catalog of possible MRI reporting elements. Subsequently, specialist members of the German Societies of Neurosurgery, Radiation Oncology, Hematology and Medical Oncology, Neurology, and Neuropathology were invited to evaluate the items with regard to their clinical relevance.

RESULTS

A total of 171 specialists from Germany participated in the survey (81 neurosurgeons, 66 radiation therapists, and 24 other neuro-oncology experts). Number and anatomic extent of tumors in the contrast-enhanced T1 and 2D T2 sequences (98.8% vs. 97.1%) as well as newly diagnosed lesions at follow-up (T1 + contrast 98.2%; T2 94.7%) were overall most frequently considered crucial. In addition, the experts particularly rated the description of ependymal and/or leptomeningeal tumor dissemination (93.6%) and signs of mass effect including occlusive hydrocephalus and parenchymal mass shifts (> 75.0% each) as essential. Standard mention of intratumoral calcifications, hemorrhages, tumor vascular architecture, or advanced imaging modalities such as MR perfusion, diffusion, tractography, and proton spectroscopy were considered fundamental to their everyday practice by only a minority of neuro-oncology colleagues.

CONCLUSION

A referring physician-oriented minimum content standard for MRI examinations in primary brain tumor patients should include as clinically relevant core elements the exact anatomic spread of the lesion(s), including ependymal and meningeal involvement, and the pertinent signs of mass effect.

摘要

背景与目的

使用基于共识的内容类别对MRI检查进行结构化报告,有可能改善神经肿瘤学中的多学科交流。因此,本研究的目的是在对从事神经肿瘤学工作的医学协会成员进行全国性调查的背景下,从临床角度确定胶质瘤成像中的基本报告类别。

材料与方法

基于跨学科制定的可能的MRI报告要素目录创建了一份在线问卷。随后,邀请德国神经外科、放射肿瘤学、血液学和医学肿瘤学、神经病学以及神经病理学协会的专家成员评估这些项目的临床相关性。

结果

共有171名来自德国的专家参与了调查(81名神经外科医生、66名放射治疗师和24名其他神经肿瘤学专家)。增强T1和二维T2序列中肿瘤的数量和解剖范围(分别为98.8%和97.1%)以及随访时新诊断的病变(T1加造影剂为98.2%;T2为94.7%)总体上最常被认为是关键的。此外,专家们特别将室管膜和/或软脑膜肿瘤播散的描述(93.6%)以及包括梗阻性脑积水和实质肿块移位在内的占位效应体征(各超过75.0%)视为必不可少的内容。只有少数神经肿瘤学同事认为在日常实践中,常规提及肿瘤内钙化、出血、肿瘤血管结构或诸如MR灌注、扩散、纤维束成像和质子波谱等先进成像方式是基本的。

结论

针对原发性脑肿瘤患者的MRI检查,以转诊医生为导向的最低内容标准应将病变的确切解剖范围(包括室管膜和脑膜受累情况)以及相关的占位效应体征作为临床相关的核心要素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/9343312/4f70b3330f7a/117_2022_1014_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/9343312/d528a4be5f05/117_2022_1014_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/9343312/4f70b3330f7a/117_2022_1014_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/9343312/d528a4be5f05/117_2022_1014_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/9343312/4f70b3330f7a/117_2022_1014_Fig2_HTML.jpg

相似文献

1
[MRI reporting of gliomas : What neuro-oncology clinicians expect from radiologists].[胶质瘤的磁共振成像报告:神经肿瘤临床医生对放射科医生的期望]
Radiologie (Heidelb). 2022 Aug;62(8):683-691. doi: 10.1007/s00117-022-01014-6. Epub 2022 May 25.
2
What to report in sellar tumor MRI? A nationwide survey among German pituitary surgeons, radiation oncologists, and endocrinologists.鞍区肿瘤 MRI 应报告哪些内容?德国垂体外科医生、放射肿瘤学家和内分泌学家的全国性调查。
Neuroradiology. 2023 Nov;65(11):1579-1588. doi: 10.1007/s00234-023-03222-w. Epub 2023 Sep 22.
3
Statement of the German Roentgen Society, German Society of Neuroradiology, and Society of German-speaking Pediatric Radiologists on Requirements for the Performance and Reporting of MR Imaging Examinations Outside of Radiology.德国放射学会、德国神经放射学会和德语国家儿科放射学会关于放射科以外磁共振成像检查的执行和报告要求的声明。
Rofo. 2021 Sep;193(9):1050-1061. doi: 10.1055/a-1463-3626. Epub 2021 Apr 8.
4
Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.儿童神经肿瘤学中的疗效评估:在新诊断的高级别胶质瘤儿科患者的随机II期试验中实施和扩展RANO标准
AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. doi: 10.3174/ajnr.A4782. Epub 2016 Apr 28.
5
MRI of the Prostate in Germany: Online Survey among Radiologists.德国前列腺的磁共振成像:放射科医生在线调查
Rofo. 2015 Aug;187(8):703-11. doi: 10.1055/s-0034-1399566. Epub 2015 Jun 11.
6
Classification of High-Grade Glioma into Tumor and Nontumor Components Using Support Vector Machine.使用支持向量机将高级别胶质瘤分类为肿瘤和非肿瘤成分
AJNR Am J Neuroradiol. 2017 May;38(5):908-914. doi: 10.3174/ajnr.A5127. Epub 2017 Apr 6.
7
Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.用于疑似低级别胶质瘤导航引导手术的标准化多模态影像方案介绍。
Neurosurg Focus. 2015 Jan;38(1):E4. doi: 10.3171/2014.10.FOCUS14597.
8
Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.WHO 分级 III 级胶质瘤切除范围的阈值:122 例术中 MRI 回顾性容积分析。
J Neurosurg. 2018 Jul;129(1):1-9. doi: 10.3171/2017.3.JNS162383. Epub 2017 Sep 8.
9
Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques.神经肿瘤学反应评估标准:使用常规和先进技术的实用方法。
AJNR Am J Neuroradiol. 2020 Jan;41(1):10-20. doi: 10.3174/ajnr.A6358. Epub 2019 Dec 19.
10
Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.通过先进的PET/MR神经成像精确描绘胶质瘤浸润(前沿研究):一项诊断研究方案
Neurosurgery. 2016 Oct;79(4):535-40. doi: 10.1227/NEU.0000000000001355.

引用本文的文献

1
Identification of key elements in MRI reporting of intracranial meningiomas based on a nationwide survey of clinical experts in Germany.基于对德国临床专家的全国性调查确定颅内脑膜瘤MRI报告中的关键要素
Sci Rep. 2025 Jan 7;15(1):1043. doi: 10.1038/s41598-024-83737-1.
2
What to report in sellar tumor MRI? A nationwide survey among German pituitary surgeons, radiation oncologists, and endocrinologists.鞍区肿瘤 MRI 应报告哪些内容?德国垂体外科医生、放射肿瘤学家和内分泌学家的全国性调查。
Neuroradiology. 2023 Nov;65(11):1579-1588. doi: 10.1007/s00234-023-03222-w. Epub 2023 Sep 22.

本文引用的文献

1
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
2
Quantitative Improvement in Brain Tumor MRI Through Structured Reporting (BT-RADS).通过结构化报告(BT-RADS)提高脑肿瘤 MRI 的定量分析
Acad Radiol. 2020 Jun;27(6):780-784. doi: 10.1016/j.acra.2019.07.028. Epub 2019 Aug 27.
3
Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice.
神经肿瘤学疗效评估(RANO)标准在临床试验和临床实践中的应用。
CNS Oncol. 2019 Mar 1;8(1):CNS28. doi: 10.2217/cns-2018-0007. Epub 2019 Feb 26.
4
Institutional Implementation of a Structured Reporting System: Our Experience with the Brain Tumor Reporting and Data System.机构实施结构化报告系统:我们使用脑肿瘤报告和数据系统的经验。
Acad Radiol. 2019 Jul;26(7):974-980. doi: 10.1016/j.acra.2018.12.023. Epub 2019 Jan 18.
5
The added prognostic value of radiological phenotype combined with clinical features and molecular subtype in anaplastic gliomas.影像学表型与临床特征和分子亚型联合在间变性神经胶质瘤中的附加预后价值。
J Neurooncol. 2019 Mar;142(1):129-138. doi: 10.1007/s11060-018-03072-0. Epub 2019 Jan 2.
6
Pseudoprogression of brain tumors.脑肿瘤的假性进展
J Magn Reson Imaging. 2018 May 7;48(3):571-89. doi: 10.1002/jmri.26171.
7
Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System.基于管理的脑肿瘤报告与数据系统对治疗后胶质瘤反应的结构化报告
J Am Coll Radiol. 2018 May;15(5):767-771. doi: 10.1016/j.jacr.2018.01.022. Epub 2018 Mar 2.
8
Structured Reporting in Neuroradiology: Intracranial Tumors.神经放射学中的结构化报告:颅内肿瘤
Front Neurol. 2018 Feb 6;9:32. doi: 10.3389/fneur.2018.00032. eCollection 2018.
9
Response Assessment in Neuro-Oncology Clinical Trials.神经肿瘤学临床试验中的疗效评估
J Clin Oncol. 2017 Jul 20;35(21):2439-2449. doi: 10.1200/JCO.2017.72.7511. Epub 2017 Jun 22.
10
Affinity Chart Analysis: A Method for Structured Collection, Aggregation, and Response to Customer Needs in Radiology.亲和图分析:一种用于放射学中结构化收集、汇总和回应客户需求的方法。
AJR Am J Roentgenol. 2017 Apr;208(4):W134-W145. doi: 10.2214/AJR.16.16673. Epub 2017 Jan 31.